Over the course of the three-day exhibition, Actover’s pavilion welcomed pharmaceutical industry executives, business delegations, professional and academic communities, university students, and domestic and international visitors. The event provided an important platform for professional engagement, industry networking, and the presentation of the Group’s capabilities across pharmaceutical manufacturing, biotechnology, specialized production, and related healthcare activities.

The Actover pavilion was visited by Dr. Mohammad-Reza Zafarghandi, Minister of Health and Medical Education; Dr. Mehdi Pir-Salehi, Head of the Food and Drug Administration (FDA); senior officials and executives from the Ministry of Health and the FDA; and members of the Board of Directors of the Iranian Syndicate of Human Pharmaceutical Industries.

Representing the Group’s broad operational and manufacturing footprint, the pavilion brought together Actoverco, Actero Middle East, Atipharmed, Alborz Zagros, Nexus, Actobiochem, Actotech, Actovercellgene, and Elite Darou. Their presence provided visitors with an integrated perspective on Actover Pharmaceutical Group’s capabilities across different segments of the pharmaceutical value chain.

A Platform for Pharmaceutical Industry Dialogue and Collaboration

With the participation of more than 670 domestic and international companies and 150 scientific and professional associations from 30 countries, the 11th Iran Pharma Exhibition served as a major industry platform for exchanging technical and professional expertise, presenting pharmaceutical innovations, strengthening business relationships, and addressing key challenges affecting the pharmaceutical sector at both national and international levels.

The exhibition brought together stakeholders representing a wide spectrum of the pharmaceutical value chain, including finished pharmaceutical manufacturers, active pharmaceutical ingredient (API) producers, pharmaceutical distributors, manufacturers of pharmaceutical equipment and machinery, pharmaceutical packaging and printing companies, biotechnology and novel-drug developers, startups, manufacturers of herbal medicines and dietary supplements, academic and research institutions, professional associations, and industry media.

For Actover Pharmaceutical Group, participation in the exhibition provided an opportunity to engage directly with this diverse stakeholder community and to strengthen professional interactions across the pharmaceutical ecosystem.

Engaging the Next Generation of Pharmaceutical Professionals

The strong participation of university student groups was among the notable features of this year’s Iran Pharma Exhibition. Students visiting Actover’s pavilion had the opportunity to gain first-hand insight into the structure and operations of a major pharmaceutical group, learn about different professional disciplines within the industry, and become familiar with potential career and professional development pathways across pharmaceutical manufacturing and related fields.

This engagement provided an important bridge between the academic community and the pharmaceutical industry, allowing students to gain a more practical understanding of the technical, scientific, operational, and professional dimensions of the sector.

Specialized Programs Addressing the Future of the Pharmaceutical Sector

Held under the theme “Iran Will Remain Healthy,” the 11th Iran Pharma Exhibition took place against the backdrop of the particular challenges and evolving conditions affecting the pharmaceutical sector in recent months.

In addition to the exhibition floor, the event featured a range of specialized forums and interactive programs designed to facilitate expert dialogue and promote knowledge exchange.

The Iran Pharma Stage served as a forum for strategic discussions on the future of Iran’s pharmaceutical industry, with experts and stakeholders examining issues related to policymaking, decision-making, industry governance, and the broader strategic environment of the pharmaceutical sector.

The Iran Pharma Talk provided a platform for conversations with pharmaceutical executives, specialists, and industry professionals, focusing on professional experiences, strategic decisions, industry challenges, and lessons learned throughout their careers.

These sessions extended beyond conventional industry reporting and quantitative indicators, placing greater emphasis on the professional experiences and perspectives of individuals who have played a role in shaping the development and future direction of Iran’s pharmaceutical industry.

Strengthening Industry-to-Industry and Institutional Engagement

Another key component of the 11th Iran Pharma Exhibition was Iran Pharma Connect, a dedicated platform designed to facilitate structured engagement and strengthen professional relationships among pharmaceutical industry stakeholders.

The program featured specialized meetings in B2B (Business-to-Business), B2G (Business-to-Government), and G2G (Government-to-Government) formats, creating opportunities for participants to discuss technical and business capabilities, industry requirements, regulatory and operational challenges, and potential areas for cooperation.

Through its participation in the 11th Iran Pharma Exhibition, Actover Pharmaceutical Group reaffirmed its engagement with the pharmaceutical industry’s professional and institutional community, while providing a platform for its affiliated companies to present their capabilities, exchange expertise, and develop meaningful connections with stakeholders across the pharmaceutical value chain.

As one of the sector’s major industry gatherings, Iran Pharma continues to provide an important setting for dialogue, collaboration, and the exchange of expertise among pharmaceutical manufacturers, regulators, academia, professional organizations, and other stakeholders shaping the future of healthcare and pharmaceutical manufacturing in Iran.